<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="2" ids="27899">Cisplatin</z:chebi>-based chemotherapy - mainly the <z:chebi fb="0" ids="3139">bleomycin</z:chebi>, <z:chebi fb="0" ids="4911">etoposide</z:chebi> and <z:chebi fb="2" ids="27899">cisplatin</z:chebi> (BEP) regimen - has significantly improved the prognosis of <z:e sem="disease" ids="C1336708" disease_type="Neoplastic Process" abbrv="TGCT">testicular germ cell tumours</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, it has serious vascular side effects, including <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>CASE REPORT: A 37-year-old man with no conventional cerebrovascular risk factors presented with right arm <z:hpo ids='HP_0002312'>clumsiness</z:hpo> followed by a transient episode of expressive <z:hpo ids='HP_0002357'>dysphasia</z:hpo> 3 h later </plain></SENT>
<SENT sid="3" pm="."><plain>He was receiving the third cycle of BEP for metastatic retroperitoneal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Brain computed tomography (CT) and diffusion-weighted magnetic resonance imaging (MRI) confirmed multiple <z:hpo ids='HP_0011009'>acute</z:hpo> infarctions in the left middle cerebral artery territory </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> angiography and CT angiography showed a dissection with flaps extending into the left internal and external carotid arteries </plain></SENT>
<SENT sid="6" pm="."><plain>The patient was anticoagulated and made an almost complete recovery </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C0338585" disease_type="Disease or Syndrome" abbrv="">Carotid artery dissection</z:e> has not been reported as the cause of <z:chebi fb="2" ids="27899">cisplatin</z:chebi>-associated <z:hpo ids='HP_0001297'>stroke</z:hpo> in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>This case demonstrates the potential for <z:chebi fb="2" ids="27899">cisplatin</z:chebi>-induced mechanisms causing carotid dissection, particularly considering the close temporal association of BEP and the event in our patient </plain></SENT>
<SENT sid="9" pm="."><plain>In young patients with excellent curative potential from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e>, every effort should be made to minimise the risk of disabling side effects of BEP </plain></SENT>
<SENT sid="10" pm="."><plain>After a <z:hpo ids='HP_0001297'>stroke</z:hpo>, imaging of intracranial and extracranial arteries, monitoring and correction of serum <z:chebi fb="131" ids="25107">magnesium</z:chebi> is recommended </plain></SENT>
<SENT sid="11" pm="."><plain>The decision to continue or discontinue <z:chebi fb="2" ids="27899">cisplatin</z:chebi>-based chemotherapy should be individualised </plain></SENT>
</text></document>